<DOC>
	<DOCNO>NCT00747708</DOCNO>
	<brief_summary>The purpose study determine whether adult bone marrow derive stem/progenitor cell improve cardiac function symptom patient heart failure establish optimal method delivery cell . Study hypotheses : - Administration G-CSF patient heart failure secondary ischaemic heart disease lead increase circulate progenitor cell measure peripheral CD34+ positive cell count - Cardiac function symptom improve patient peripheral CD34+ count increase response G-CSF administration - Direct coronary injection autologous bone marrow derive stem cell confer additional improvement cardiac function symptom derive G-CSF infusion alone - Direct intramyocardial injection autologous bone marrow derive stem cell lead improvement cardiac function symptom derive G-CSF infusion alone</brief_summary>
	<brief_title>Bone Marrow Derived Adult Stem Cells Chronic Heart Failure</brief_title>
	<detailed_description>The study involve three arm compare method autologous bone marrow cel administration patient chronic heart failure . Each arm comparative group contain either saline injection ( peripheral arm injects GCSF alone ) serum ( two interventional arms-intracoronary intramyocardial injection ) . The protocol ( advice ethic committee ) divide 58 patient pilot study follow recruitment intramyocardial arm ( 30 patient randomise 1:1 cell serum vs serum alone ) recruitment intracoronary peripheral arm ( 30 patient randomise 1:1 cell serum vs serum alone arm ) . The study power around use advance imaging measure within group change ejection fraction 12 month primary end point .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Symptomatic patient diagnosis heart failure secondary ischaemic heart disease optimal heart failure treatment treatment option available Patient consider implantable defibrillator keep NICE guideline Recent acute coronary syndrome judge rise Troponin normal value last 6 month The presence cardiogenic shock The presence acute leave and/or rightsided pump failure judge presence pulmonary oedema and/or new peripheral oedema Known severe preexistent leave ventricular dysfunction ( ejection fraction &lt; 10 % prior randomisation ) Congenital cardiac disease Cardiomyopathy secondary reversible cause e.g . thyroid disease , alcohol abuse , hypophosphataemia , hypocalcaemia , cocaine abuse , selenium toxicity &amp; chronic uncontrolled tachycardia Cardiomyopathy association neuromuscular disorder e.g . Duchenne 's progressive muscular dystrophy Contraindication bone marrow aspiration Known active infection Known infection human immunodeficiency virus ( HIV ) , hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) syphilis HTLV Lifestyle high risk infection HIV , HBV HCV syphilis HTLV Serum creatinine &gt; 200 umol/L Chronic inflammatory disease Serious know concomitant disease life expectancy le one year Followup impossible ( fixed abode , etc ) Previous participation study Female subject childbearing potential Atrial fibrillation Patients respond implantation biventricular pacemaker Weight &gt; 140kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>heart failure</keyword>
	<keyword>coronary heart disease</keyword>
	<keyword>adult stem cell</keyword>
	<keyword>bone marrow progenitor cell</keyword>
	<keyword>bone marrow stem cell</keyword>
	<keyword>autologous</keyword>
	<keyword>granulocyte-colony stimulating factor</keyword>
	<keyword>leave ventricular function</keyword>
	<keyword>intracoronary injection</keyword>
	<keyword>intramyocardial injection</keyword>
</DOC>